Accéder au site de la conférence

Innovations in immuno-oncology: from data to therapeutic insights

16-16 oct. 2025
IUCT-Oncopole Amphitheater (1 Avenue Irène Joliot-Curie, 31100 Toulouse) - Toulouse (France)

https://immunoncoinfo.sciencesconf.org

Immuno-oncology workshop The Immuno-oncology workshop, organized by PhD students from the Toulouse Cancer Research Center (CRCT), will take place on Thursday, October 16th, 2025, at the IUCT-Oncopole Amphitheater (1 Avenue Irène Joliot-Curie, 31100 Toulouse). This event is designed to connect researchers and clinicians around the latest developments in immuno-oncology, bridging computational innovation and clinical application. Scientific overview The immune system plays a key role in cancer because it can detect and eliminate tumor cells through multiple biological mechanisms. Over the last decade, deep exploration of immune-tumor interactions has opened the door to immunotherapies that have reshaped cancer care. Despite these advances, challenges remain: not all patients respond to treatment, and resistance can develop. New strategies increasingly rely upon the integration of bioinformatics and computational modeling to address all of these gaps and to better understand tumor-immune dynamics, as well as design personalized interventions for predicting therapeutic outcomes. This workshop will present diverse perspectives regarding how multidisciplinary research is shaping the next generation of cancer therapies, from laboratory discoveries to computational frameworks and clinical trials. Invited speakers Dr. Jasmin Fisher UCL Cancer Institute, University College London, UK Cancer Digital Twins Dr. Sébastien Benzekry COMPO, Inria and Cancer Research Center of Marseille (Inserm, Aix-Marseille University, Paoli Calmettes Institute) Mechanistic learning to predict response and survival in immuno-oncology Dr. Noémie Leblay Arthur J.E. Child Comprehensive Cancer Center, University of Calgary, Canada Tolerogenic dendritic cells and immunosuppressive milieu cause resistance to daratumumab and IMiDs in multiple myeloma Dr. Gaoussou Sanou IGH – Institut de Génétique Humaine (CNRS, Université de Montpellier) IMGT/mAb-KG: the IMGT-KG dedicated to monoclonal antibodies Additional program highlights The workshop will also feature contributions from PhD students and post-doctoral researchers, offering a comprehensive overview of ongoing immuno-oncology projects in the Toulouse region and beyond. Sponsored by: CARe, SFR-B2S, and other partners. Organizing committee: Benoit Aliaga, Hugo Chenel, Hafida Hamdache, Marcelo Hurtado Acknowledgements: Pierre Cordelier, Roxana Khazen, Ludovic Martinet, Vera Pancaldi, Bruno Segui Technical and administrative support: Marion Domingues, Claire Mendoza Berrio, Christa Rachelle Joseph Special thanks: CARe PhD students, Victoria Bruning, Ambroise Jezequel, Nadine Gheziel, Lisa Gutkowski, Frecia Rodriguez
Discipline scientifique :  Intelligence artificielle - Bio-informatique - Mathématiques - Statistiques - Bio-Informatique, Biologie Systémique - Cancer - Immunologie - Immunothérapie

Lieu de la conférence
   Contact |  À propos |  RSS |  Vie privée |  Accessibilité